Anionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide- methotrexate nanohybrid in C33A orthotopic cervical cancer model
Files
(Published version)
Date
2016
Authors
Choi, G.
Piao, H.
Alothman, Z.A.
Vinu, A.
Yun, C.O.
Choy, J.H.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
International Journal of Nanomedicine, 2016; 11:337-348
Statement of Responsibility
Conference Name
Abstract
Methotrexate (MTX), an anticancer agent, was successfully intercalated into the anionic clay, layered double hydroxides to form a new nanohybrid drug. The coprecipitation and subsequent hydrothermal method were used to prepare chemically, structurally, and morpho- logically well-defined two-dimensional drug-clay nanohybrid. The resulting two-dimensional drug-clay nanohybrid showed excellent colloidal stability not only in deionized water but also in an electrolyte solution of Dulbecco’s Modified Eagle’s Medium with 10% fetal bovine serum, in which the average particle size in colloid and the polydispersity index were determined to be around 100 and 0.250 nm, respectively. The targeting property of the nanohybrid drug was confirmed by evaluating the tumor-to-blood and tumor-to-liver ratios of the MTX with anionic clay carrier, and these ratios were compared to those of free MTX in the C33A orthotopic cer- vical cancer model. The biodistribution studies indicated that the mice treated with the former showed 3.5-fold higher tumor-to-liver ratio and fivefold higher tumor-to-blood ratio of MTX than those treated with the latter at 30 minutes postinjection.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2015 Choi et al (http://creativecommons.org/licenses/by-nc/3.0/)
Access Condition Notes: Creative Commons Attribution – Non Commercial (unported, v3.0)License. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.